Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Products & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Hospital and Nursing Home Probiotics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related Market Outlook
3.2. Industry Value Chain Analysis
3.2.1. Profit Margin Analysis (Industry-level)
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.5. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Product Adoption
4.5. Observations & Recommendations
Chapter 5. U.S. Hospital and Nursing Home Probiotics Market: Channel Estimates & Trend Analysis
5.1. U.S. Hospital and Nursing Home Probiotics Market, By Channel: Key Takeaways
5.2. Channel Movement Analysis & Market Share, 2024 & 2030
5.3. Market Estimates & Forecasts, By Channel, 2018 - 2030 (USD Million)
5.3.1. Hospital
5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.2. Nursing Home
5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. U.S. Hospital and Nursing Home Probiotics Market: Function Estimates & Trend Analysis
6.1. U.S. Hospital and Nursing Home Probiotics Market, By Function: Key Takeaways
6.2. Function Movement Analysis & Market Share, 2024 & 2030
6.3. Market Estimates & Forecasts, by Function, 2018 - 2030 (USD Million)
6.3.1. Gut Health
6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.2. Immunity
6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Wellness
6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Others
6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. U.S. Hospital and Nursing Home Probiotics Market: Competitive Analysis
7.1. Recent developments & impact analysis, by key market participants
7.2. Company Categorization
7.3. Participant’s Overview
7.4. Financial Performance
7.5. Product Benchmarking
7.6. Company Heat Map Analysis
7.7. Strategy Mapping
7.8. Company Profiles
7.8.1. Bio-K+, a Kerry company
7.8.1.1. Company Overview
7.8.1.2. Financial Performance
7.8.1.3. Product Portfolios
7.8.1.4. Strategic Initiatives
7.8.2. American Lifeline Inc.
7.8.2.1. Company Overview
7.8.2.2. Financial Performance
7.8.2.3. Product Portfolios
7.8.2.4. Strategic Initiatives
7.8.3. Rising Pharmaceuticals
7.8.3.1. Company Overview
7.8.3.2. Financial Performance
7.8.3.3. Product Portfolios
7.8.3.4. Strategic Initiatives
7.8.4. BD
7.8.4.1. Company Overview
7.8.4.2. Financial Performance
7.8.4.3. Product Portfolios
7.8.4.4. Strategic Initiatives
7.8.5. Dietary Pros, Inc.
7.8.5.1. Company Overview
7.8.5.2. Financial Performance
7.8.5.3. Product Portfolios
7.8.5.4. Strategic Initiatives
7.8.6. Dr. Joseph Mercola
7.8.6.1. Company Overview
7.8.6.2. Financial Performance
7.8.6.3. Product Portfolios
7.8.6.4. Strategic Initiatives
7.8.7. i-Health, Inc.
7.8.7.1. Company Overview
7.8.7.2. Financial Performance
7.8.7.3. Product Portfolios
7.8.7.4. Strategic Initiatives
7.8.8. Probi
7.8.8.1. Company Overview
7.8.8.2. Financial Performance
7.8.8.3. Product Portfolios
7.8.8.4. Strategic Initiatives
7.8.9. Lallemand Inc.
7.8.9.1. Company Overview
7.8.9.2. Financial Performance
7.8.9.3. Product Portfolios
7.8.9.4. Strategic Initiatives
7.8.10. Chr. Hansen A/S, part of Novonesis
7.8.10.1. Company Overview
7.8.10.2. Financial Performance
7.8.10.3. Product Portfolios
7.8.10.4. Strategic Initiatives
7.8.11. Biocodex
7.8.11.1. Company Overview
7.8.11.2. Financial Performance
7.8.11.3. Product Portfolios
7.8.11.4. Strategic Initiatives
7.8.12. Probiotical S.p.A.
7.8.12.1. Company Overview
7.8.12.2. Financial Performance
7.8.12.3. Product Portfolios
7.8.12.4. Strategic Initiatives
7.8.13. Protexin
7.8.13.1. Company Overview
7.8.13.2. Financial Performance
7.8.13.3. Product Portfolios
7.8.13.4. Strategic Initiatives
List of Tables
Table 1 U.S. hospital and nursing home probiotics market: Key market driver analysis
Table 2 U.S. hospital and nursing home probiotics market: Key market restraint analysis
Table 3 U.S. hospital and nursing home probiotics market estimates & forecast, by channel (USD Million)
Table 4 U.S. hospital and nursing home probiotics market estimates & forecast, by function (USD Million)
Table 5 U.S. hospital probiotics market estimates & forecast, by number of beds (USD Million)
Table 6 U.S. hospital probiotics market estimates & forecast, by payer (USD Million)
Table 7 U.S. hospital probiotics market estimates & forecast, by location (USD Million)
Table 8 U.S. nursing home probiotics market estimates & forecast, by number of beds (USD Million)
Table 9 U.S. nursing home probiotics market estimates & forecast, by payer (USD Million)
Table 10 U.S. nursing home probiotics market estimates & forecast, by ownership (USD Million)
Table 11 Recent developments & impact analysis, by key market participants
Table 12 Company heat map analysis, 2024
Table 13 Companies implementing key strategies
List of Figures
Fig. 1 U.S. hospital and nursing home probiotics market segmentation
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Primary research approaches
Fig. 5 Primary research process
Fig. 6 Market snapshot
Fig. 7 Segment snapshot
Fig. 8 Regional snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Global parent industry and U.S. hospital and nursing home probiotics market size (USD Million)
Fig. 11 U.S. hospital and nursing home probiotics market size, 2018 to 2030 (USD Million)
Fig. 12 U.S. hospital and nursing home probiotics market: Penetration & growth prospect mapping
Fig. 13 U.S. hospital and nursing home probiotics market: Value chain analysis
Fig. 14 U.S. hospital and nursing home probiotics market: Dynamics
Fig. 15 U.S. hospital and nursing home probiotics market: Porter’s five forces analysis
Fig. 16 U.S. hospital and nursing home probiotics market estimates & forecast, by channel (USD Million)
Fig. 17 Hospitals market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 18 Nursing homes market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 19 U.S. hospital and nursing home probiotics market estimates & forecast, by function (USD Million)
Fig. 20 Gut health market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 21 Immunity market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 22 Wellness market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 23 Other functions market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 24 Key company categorization
Fig. 25 Strategic framework of U.S. hospital and nursing home probiotics